News

  1. Home ›
  2. News
    3. (: Page 55)

NGS-Based HLA Genotyping: Omixon and CHOP Collaborate

04/06/2014
Omixon is very proud to announce an exclusive licensing agreement with The Children’s Hospital of Philadelphia (CHOP) to commercialize a new Next Generation Sequencing (NGS) HLA genotyping assay, for use on the Illumina® MiSeq sequencing platform. The Illumina-specific HLA genotyping protocol was developed by Professor Dimitri Monos, Director of the...

 

Read more

Omixon Raises Capital, Launches US Office

14/05/2014
Omixon has opened its first offices in Cambridge, MA to support the growing demand from customers for their HLA genotyping software, Omixon Target™ HLA Typing. The US office will be responsible for all in-market activities relating to sales, support and training for Omixon’s products with an additional focus on business...

 

Read more

Omixon Awarded 100k Genome Research Grant

09/05/2014
Winners from a £10 million competition to help businesses develop new technology to map and analyse genes have been announced on 2 May. Eight companies were successful and will share a total of £1.6 million. The winners will use this funding from phase 1 of the competition to demonstrate the...

 

Read more

Omixon at This Year’s Immuno B4B-Connection Conference!

06/05/2014
Agnes Pasztor, Omixon’s Customer Support Manager and our French distributor WiraTech Europe‘s CEO Sami Djoulah, attended this year’s Immuno B4B-Connection in Charleroi Biopark, Belgium. At least 120 people from different companies participated in the 2 day conference, consisting of various presentations and introductions to the many different companies and their field of interest. A...

 

Read more